Skip to main content
ToolsForensic Analysisacino pharma

acino pharma

Supplier Forensic Analysis · Scanned: 2026/06/24

Disclaimer: Statistical patterns flagged for review only. This tool does not determine or imply wrongdoing. All findings require independent verification.
Risk Score
Forensic risk score: 0 out of 100. LOW RISK.Forensic risk score: 0 out of 100. LOW RISK.
0RISK SCORE
LOW RISK
Compliance
N/A/100
Awards
4
Total Value
R 123M

Recent Awards

4 awards · Total: R 123 155 760,11

Showing 5 of 4
HP02-2025AI: Supply and Delivery of Anti-Infective Medicines (Antibiotics, Antifungal, Antiprotozoal and Antiviral Agents) to the Department of Health for the period 1 October 2025 to 30 September 2028.
Health
Ref: HP02-2025AI
R 1 074 779,48
21 Aug 2025
Supply and Delivery of Small Volume Parenterals and Insulin Devices to the Department of Health for the period ending 30 April 2027.
Health
Ref: HP06-2024SVP/01
R 15 873 982,80
24 Oct 2024
Supply and Delivery of Anti-Infective Medicines (Antibiotics, Antifungal, Antiprotozoal and Antiviral Agents) to the Department of Health for the period 1 October 2023 to 30 September 2025
Health
Ref: HP02-2023AI
R 102 886 124,63
15 Jun 2023
SUPPLY AND DELIVERY OF SEMI-SOLID DOSAGE FORMS AND POWDERS TO THE DEPARTMENT OF HEALTH FOR THE PERIOD 1 JULY 2023 TO 30 JUNE 2026 ERRATUM 1: PLEASE NOTE THAT THE SPECIAL REQUIREMENTS AND CONDITIONS OF CONTRACT (SRCC) AS PUBLISHED WITH THE BID PACK ON 17 JUNE 2022 FOR TENDER HP08-2023SSP IS BEING REPLACED WITH THIS ERRATUM.
Health
Ref: HP08-2023SSP
R 3 320 873,20
13 Feb 2023

AI Analysis

Powered by Gemini

AI Forensic Analysis

Get AI-generated audit narratives with key findings and recommended actions.
Paid access from R499/mo

or upgrade to Pro Subscription

Risk Assessment

Forensic risk score: 0 out of 100. LOW RISK.Forensic risk score: 0 out of 100. LOW RISK.
0RISK SCORE
LOW RISK

Based on 0 forensic flags detected

Unlock Full Analysis

Get access to all forensic flags, evidence details, and AI-generated audit narratives.

View Full Intelligence Report

Get complete award history, director network, and compliance analysis.

View Report →